Litigator Mark H. Izraelewicz aggressively protects the interests of clients in the chemical and biotech industries. From defending against infringement claims to prosecuting their claims through trial, he's proved an insightful and thorough attorney. Mr. Izraelewicz's ability to analyze and master issues efficiently, flows from his training as a scientist, with his Masters in chemistry, cutting edge research at The Scripps Research Institute, as well as applied work at Abbott Labs. In U.S. District Courts, he has favorably resolved many cases short of trial and has shown in four major cases his adeptness at litigating trials successfully.
Recent Client Work:
Successfully tried a case concerning the ownership of patents covering Applied Biosystems's next-generation DNA sequencing machines for Illumina in the U.S. District Court for the Northern District of California.
As a key member of the trial team, successfully protected Amgen and its blockbuster drug Epogen® against an attempt by Hoffman-LaRoche to bring a competing product to market in the U.S. District Court for Massachusetts.
After a one week trial, secured a favorable settlement for Infosoft in a trade secret matter brought by Bob Creeden and Associates in the U.S. District Court for the Northern District of Illinois.
Successfully tried Golden Voice's patent infringement against Rockwell International in the U.S. District Court for the Middle District of Florida.
Background and Credentials:
In addition to his extensive practice in patent litigation, Mark Izraelewicz assists clients in all other aspects of patent practice. As a litigator, he has argued a variety of substantive motions, participated in Markman hearings, and won motions for summary judgment.
He received his law degree from The University of Chicago Law School, where he was a Baker Scholar.
Prior to law school, Mr. Izraelewicz was a chemist at Abbott Laboratories in North Chicago, where he was involved in the production of large quantities of drug candidates for use in biological testing.
While receiving a Masters of Science from the University of California-San Diego, Mr. Izraelewicz received the Harold C. Urey Graduate Fellowship. As a graduate student, he engaged in cutting edge research at The Scripps Research Institute under the direction of Professor K.C. Nicolaou. His graduate research was directed towards the total synthesis of complex naturally occurring compounds.
He received a Bachelors of Science in chemistry from the State University of New York at Buffalo. Mr. Izraelewicz conducted research in chemistry and biochemistry and received the Ronald E. McNair Undergraduate Research Fellowship for the promotion of undergraduate scientific research.